RDF/XMLNTriplesTurtleShow queryShare
SubjectPredicateObject
http://purl.uniprot.org/citations/34097504http://www.w3.org/1999/02/22-rdf-syntax-ns#typehttp://purl.uniprot.org/core/Journal_Citation
http://purl.uniprot.org/citations/34097504http://www.w3.org/2000/01/rdf-schema#comment"Whooping cough (pertussis) is a severe pulmonary infectious disease caused by the bacteria Bordetella pertussis. Pertussis infects an estimated 24 million people annually, resulting in >150,000 deaths. The NIH placed pertussis on the list of emerging pathogens in 2015. Antibiotics are ineffective unless administered before the onset of the disease characteristic cough. Therefore, there is an urgent need for novel pertussis therapeutics. We have shown that sphingosine-1-phosphate receptor (S1PR) agonists reduce pertussis inflammation without increasing bacterial burden. Transcriptomic studies were performed to identify this mechanism and allow for the development of pertussis therapeutics that specifically target problematic inflammation without sacrificing bacterial control. These data suggested a role for triggering receptor expressed on myeloid cells-1 (TREM-1). TREM-1 cell surface receptor functions as an amplifier of inflammatory responses. Expression of TREM-1 is increased in response to bacterial infection of mucosal surfaces. In mice, B. pertussis infection results in Toll-like receptor 9 (TLR9)-dependent increased expression of TREM-1 and its associated cytokines. Interestingly, S1PR agonists dampen pulmonary inflammation and TREM-1 expression. Mice challenged intranasally with B. pertussis and treated with ligand-dependent (LP17) and ligand-independent (GF9) TREM-1 inhibitors showed no differences in bacterial burden and significantly reduced tumor necrosis factor-α (TNF-α) and C-C motif chemokine ligand 2 (CCL-2) expression compared to controls. Mice receiving TREM-1 inhibitors showed reduced pulmonary inflammation compared to controls, indicating that TREM-1 promotes inflammatory pathology, but not bacterial control, during pertussis infection. This implicates TREM-1 as a potential therapeutic target for the treatment of pertussis."xsd:string
http://purl.uniprot.org/citations/34097504http://purl.org/dc/terms/identifier"doi:10.1128/iai.00126-21"xsd:string
http://purl.uniprot.org/citations/34097504http://purl.uniprot.org/core/author"Carbonetti N.H."xsd:string
http://purl.uniprot.org/citations/34097504http://purl.uniprot.org/core/author"Scanlon K.M."xsd:string
http://purl.uniprot.org/citations/34097504http://purl.uniprot.org/core/author"Sigalov A.B."xsd:string
http://purl.uniprot.org/citations/34097504http://purl.uniprot.org/core/author"Skerry C."xsd:string
http://purl.uniprot.org/citations/34097504http://purl.uniprot.org/core/author"Gallop D."xsd:string
http://purl.uniprot.org/citations/34097504http://purl.uniprot.org/core/author"Ardanuy J."xsd:string
http://purl.uniprot.org/citations/34097504http://purl.uniprot.org/core/date"2021"xsd:gYear
http://purl.uniprot.org/citations/34097504http://purl.uniprot.org/core/name"Infect Immun"xsd:string
http://purl.uniprot.org/citations/34097504http://purl.uniprot.org/core/pages"e0012621"xsd:string
http://purl.uniprot.org/citations/34097504http://purl.uniprot.org/core/title"Triggering Receptor Expressed on Myeloid Cells-1 (TREM-1) Contributes to Bordetella pertussis Inflammatory Pathology."xsd:string
http://purl.uniprot.org/citations/34097504http://purl.uniprot.org/core/volume"89"xsd:string
http://purl.uniprot.org/citations/34097504http://www.w3.org/2004/02/skos/core#exactMatchhttp://purl.uniprot.org/pubmed/34097504
http://purl.uniprot.org/citations/34097504http://xmlns.com/foaf/0.1/primaryTopicOfhttps://pubmed.ncbi.nlm.nih.gov/34097504
http://purl.uniprot.org/uniprot/#_Q14DT9-mappedCitation-34097504http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/34097504
http://purl.uniprot.org/uniprot/#_Q9JKE2-mappedCitation-34097504http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/34097504
http://purl.uniprot.org/uniprot/Q9JKE2http://purl.uniprot.org/core/mappedCitationhttp://purl.uniprot.org/citations/34097504
http://purl.uniprot.org/uniprot/Q14DT9http://purl.uniprot.org/core/mappedCitationhttp://purl.uniprot.org/citations/34097504